Show simple item record

dc.contributor.advisorCastro, Carmen
dc.contributor.authorGomez-Oliva, Ricardo 
dc.contributor.authorGeribaldi-Doldán, Noelia 
dc.contributor.authorDomínguez-García, Samuel 
dc.contributor.authorGómez Oliva, Ricardo 
dc.contributor.authorGeribaldi Doldán, Noelia 
dc.contributor.authorDomínguez García, Samuel 
dc.contributor.authorPardillo Díaz, Ricardo 
dc.contributor.authorMartínez Ortega, Sergio
dc.contributor.authorOliva Montero, José María 
dc.contributor.authorPérez García, Patricia 
dc.contributor.authorGarcía Cózar, Francisco José 
dc.contributor.authorMuñoz Miranda, Juan Pedro 
dc.contributor.authorSánchez Gomar, Ismael 
dc.contributor.authorNunez Abades, Pedro
dc.contributor.authorCastro González, Carmen 
dc.contributor.otherAnatomía y Embriología Humanaes_ES
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2024-02-05T11:49:40Z
dc.date.available2024-02-05T11:49:40Z
dc.date.issued2023-11-30
dc.identifier.issn1479-5876
dc.identifier.urihttp://hdl.handle.net/10498/30600
dc.description.abstractBackground Neurogenesis is stimulated in the subventricular zone (SVZ) of mice with cortical brain injuries. In most of these injuries, newly generated neuroblasts attempt to migrate toward the injury, accumulating within the corpus callosum not reaching the perilesional area. Methods We use a murine model of mechanical cortical brain injury, in which we perform unilateral cortical injuries in the primary motor cortex of adult male mice. We study neurogenesis in the SVZ and perilesional area at 7 and 14 dpi as well as the expression and concentration of the signaling molecule transforming growth factor alpha (TGF-α) and its receptor the epidermal growth factor (EGFR). We use the EGFR inhibitor Afatinib to promote neurogenesis in brain injuries. Results We show that microglial cells that emerge within the injured area and the SVZ in response to the injury express high levels of TGF-α leading to elevated concentrations of TGF-α in the cerebrospinal fluid. Thus, the number of neuroblasts in the SVZ increases in response to the injury, a large number of these neuroblasts remain immature and proliferate expressing the epidermal growth factor receptor (EGFR) and the proliferation marker Ki67. Restraining TGF-α release with a classical protein kinase C inhibitor reduces the number of these proliferative EGFR+ immature neuroblasts in the SVZ. In accordance, the inhibition of the TGF-α receptor, EGFR promotes migration of neuroblasts toward the injury leading to an elevated number of neuroblasts within the perilesional area. Conclusions Our results indicate that in response to an injury, microglial cells activated within the injury and the SVZ release TGF-α, activating the EGFR present in the neuroblasts membrane inducing their proliferation, delaying maturation and negatively regulating migration. The inactivation of this signaling pathway stimulates neuroblast migration toward the injury and enhances the quantity of neuroblasts within the injured area. These results suggest that these proteins may be used as target molecules to regenerate brain injuries.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherBioMed Central Ltdes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceJournal of Translational Medicine, 2023 Vol. 21 n.1es_ES
dc.subjectneurogenesises_ES
dc.subjecttraumatic brain injuryes_ES
dc.subjectneuroblast migrationes_ES
dc.subjectAfatinibes_ES
dc.subjectEpidermal growth factores_ES
dc.subjecttransforming growth factor alphaes_ES
dc.titleTargeting epidermal growth factor receptor to recruit newly generated neuroblasts in cortical brain injurieses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1186/s12967-023-04707-1
dc.relation.projectIDAgencia Estatal de Investigación (Grant numbers RTI-2018–099908-B-C21es_ES
dc.relation.projectIDConsejería de Economía, Conocimiento, Empresas y Universidades (Grant number FEDER-UCA18-106647)es_ES
dc.relation.projectIDResearch and Innovation in Biomedical and Health sciences, within the framework of the Integrated Territorial Initiative 2014-2020, for the province of Cádiz. Project co-financed 80% by the European Union, within the framework of the Operational Program ERDF Andalusia 2014-2020 (Grant number ITI-Cadiz-2019–0042).es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional